Back
Spero Therapeutics 10K Form
Sell
43
SPRO
Spero Therapeutics
Last Price:
1.59
Seasonality Move:
-16.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SPRO News And Ratings
See the #1 stock for the next 7 days that we like better than SPRO
SPRO Financial Statistics
Sales & Book Value
| Annual Sales: | $96.74M |
|---|---|
| Cash Flow: | $5.94M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.79 |
| Price / Book: | 0.89 |
Profitability
| EPS (TTM): | 0.44000 |
|---|---|
| Net Income (TTM): | $23.4M |
| Gross Margin: | $7.4M |
| Return on Equity: | 31.08% |
| Return on Assets: | 17.5% |
Spero Therapeutics Earnings Forecast
Key Spero Therapeutics Financial Ratios
- The Gross Profit Margin over the past 10 years for SPRO is 54.81%.
- The Selling, General & Administrative Expenses for SPRO have been equal to 26.42% of Gross Profit Margin.
- The Research & Development expenses have been 53.18% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of SPRO is 23.58% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 8 years.
Spero Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SPRO |
| CUSIP: | 84833T |
| Website: | sperotherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.35 |
| Quick Ratio: | 3.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.7 |
|---|---|
| Forward P/E Ratio: | 0 |
SPRO Technical Analysis vs Fundamental Analysis
Sell
43
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy or a Sell?
-
Spero Therapeutics stock is rated a Sell
The current Spero Therapeutics [SPRO] share price is $1.59. The Score for SPRO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.